Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
10 Juillet 2023 - 1:30PM
Syneos Health® (Nasdaq:SYNH), a leading fully integrated
biopharmaceutical solutions organization, today announced the
appointment of Hillary Bochniak as Chief Human Resources Officer,
effective July 10, 2023.
Ms. Bochniak joins Syneos Health from Accenture where she spent
nearly 30 years in human resources (HR) roles of increasing scope
and responsibility. Most recently, she served as the Managing
Director, Global HR Lead for Strategic Accounts and Sales, where
she was a driving force behind Accenture’s sales transformation. In
this role, she collaborated closely with business leadership to
reimagine a best-in-class sales professional experience to create
customer value at scale.
“Our people are the foundation to being the solutions partner of
choice to the biopharmaceutical industry,” said Michelle Keefe,
CEO, Syneos Health. “Hillary is a proven leader who brings a
forward-thinking approach to talent development. She’ll play an
instrumental role in transformation, executing our people strategy
and building an inclusive culture.”
“I was immediately drawn to Syneos Health’s lab to life vision
and was impressed by Michelle’s ambition and authenticity in the
way she puts talent on par with other strategic initiatives,” said
Ms. Bochniak. “I am thrilled to join the Company during this
exciting time in its growth story and look forward to collaborating
alongside each and every employee – with purpose.”
Ms. Bochniak held various HR roles at Accenture that focused on
strategic talent planning and management, resource planning, HR
operations, change management and implementation of enterprise-wide
technology solutions. She holds an MBA from the College of William
and Mary and a B.A. from the University of North Carolina at Chapel
Hill.
About Syneos Health Syneos Health®
(Nasdaq:SYNH) is a leading fully integrated biopharmaceutical
solutions organization built to accelerate customer success. We
translate unique clinical, medical affairs and commercial insights
into outcomes to address modern market realities.
We bring together a talented team of professionals, who work
across more than 110 countries, with a deep understanding of
patient and physician behaviors and market dynamics. Together
we share insights, use the latest technologies and apply advanced
business practices to speed our customers’ delivery of important
therapies to patients.
Syneos Health supports a diverse, equitable and inclusive
culture that cares for colleagues, customers, patients, communities
and the environment.
To learn more about how we are Shortening the distance
from lab to life®, visit
syneoshealth.com or subscribe to our podcast.
Investor Relations Contact: |
Press/Media Contact: |
Ronnie Speight |
Gary Gatyas |
Senior Vice President, Investor Relations |
Executive Director, External Communications |
+1 919 745 2745 |
+1 908 763 3428 |
Investor.Relations@syneoshealth.com |
gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Syneos Health (NASDAQ:SYNH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024